STAND. COM. REP. NO. 1202-18

Honolulu, Hawaii

, 2018

RE: S.B. No. 2659

S.D. 1

H.D. 1

Honorable Scott K. Saiki

Speaker, House of Representatives

Twenty-Ninth State Legislature

Regular Session of 2018

State of Hawaii

Sir:

Your Committee on Health & Human Services, to which was referred S.B. No. 2659, S.D. 1, entitled:

"A BILL FOR AN ACT RELATING TO MEDICAL CANNABIS PRODUCTS,"

begs leave to report as follows:

The purpose of this measure is to update the term transdermal patches to transdermal devices in section 329D-10, Hawaii Revised Statutes, thereby including non-patch devices that deliver through the dermis. This measure also adds cannabinoid suppositories to the list of cannabis products that may be manufactured and distributed by dispensaries.

The Department of Health provided comments on this measure.

Your Committee notes the concerns raised by the Department of Health at the public hearing. Regarding adding suppositories as an authorized product, the Department could not find articles in the medical literature on tetrahydrocannabinol or cannabinoid suppositories. As a result, it would appear there is insufficient experience with this delivery system to know whether it is safe or to opine on a safe dose. The Department acknowledges that adding suppositories as an allowed product came from the Medical Cannabis Legislative Oversight Working Group and that the Department was represented on the Working Group. Nevertheless, the Department respectfully requested that this Committee omit suppositories from the list of allowed cannabis products until its medical basis can be determined.

Your Committee amended the effective date of this measure to July 1, 3000, to continue further discussion.

As affirmed by the record of votes of the members of your Committee on Health & Human Services that is attached to this report, your Committee is in accord with the intent and purpose of S.B. No. 2659, S.D. 1, as amended herein, and recommends that it pass Second Reading in the form attached hereto as S.B. No. 2659, S.D. 1, H.D. 1, and be referred to your Committee on Consumer Protection & Commerce.

Respectfully submitted on behalf of the members of the Committee on Health & Human Services,

____________________________

JOHN M. MIZUNO, Chair